Current and future treatment options for polycythemia vera Martin GriesshammerHeinz GisslingerRuben Mesa Review Article Open access 02 April 2015 Pages: 901 - 910
Oral anticoagulation to prevent thrombosis recurrence in polycythemia vera and essential thrombocythemia Juan-Carlos Hernández-BoludaEduardo Arellano-Rodrigoon behalf of the Grupo Español de Enfermedades Mieloproliferativas Filadelfia Negativas (GEMFIN) Original Article 14 February 2015 Pages: 911 - 918
A multi-state model approach for prediction in chronic myeloid leukaemia Michael LausekerJoerg HasfordGerman CML Study Group Original Article 03 December 2014 Pages: 919 - 927
Prognostic significance of diagnosed WT1 level in acute myeloid leukemia: a meta-analysis Yang Yi-ningWang Xiao-ruiQin You-wen Original Article 10 January 2015 Pages: 929 - 938
A 5-year follow-up in deferasirox treatment: improvement of cardiac and hepatic iron overload and amelioration in cardiac function in thalassemia major patients E. CassinerioA. RoghiM. D. Cappellini Original Article 08 January 2015 Pages: 939 - 945
Rabbit antithymocyte globulin versus horse antithymocyte globulin for treatment of acquired aplastic anemia: a retrospective analysis Carlos VallejoPau MontesinosThe Bone Marrow Failure Spanish Study Group (Pethema-GETH) Original Article 13 February 2015 Pages: 947 - 954
Porcine antilymphocyte globulin (p-ALG) plus cyclosporine A (CsA) treatment in acquired severe aplastic anemia: a retrospective multicenter analysis Jia WeiZhiping HuangYicheng Zhang Original Article 11 February 2015 Pages: 955 - 962
Evaluation of bone marrow involvement in extranodal NK/T cell lymphoma by FDG-PET/CT Zhiyuan ZhouChangying ChenMingzhi Zhang Original Article 30 December 2014 Pages: 963 - 967
Antibiotic treatment as sole management of Helicobacter pylori-negative gastric MALT lymphoma: a single center experience with prolonged follow-up Markus RadererStefan WöhrerAndreas Chott Original Article 13 January 2015 Pages: 969 - 973
General features and epidemiology of lymphoma in Colombia. A multicentric study Juan F. CombarizaMilton LombanaMarcos Arango Original Article 03 February 2015 Pages: 975 - 980
Impact of prior treatment on outcome of transformed follicular lymphoma and relapsed de novo diffuse large B cell lymphoma: a retrospective multicentre analysis K. LerchA. H. MeyerC. W. Scholz Original Article 03 February 2015 Pages: 981 - 988
Modified ESHAP regimen for relapsed/refractory T cell lymphoma: a retrospective analysis Yasunori KogureAkihide YoshimiMineo Kurokawa Original Article 17 February 2015 Pages: 989 - 994
Diffuse thyroid 18F-FDG uptake after R-CHOP therapy predicts favorable outcome in patients with DLBCL Moo-Kon SongJoo-Seop ChungHo-Jin Shin Original Article 17 February 2015 Pages: 995 - 1001
First-line treatments for chronic lymphocytic leukaemia: interpreting efficacy data by network meta-analysis Andrea MessoriValeria FaddaSabrina Trippoli Original Article 14 February 2015 Pages: 1003 - 1009
IgM MGUS associated with anti-MAG neuropathy: a single institution experience Giampaolo TalamoMuhammad A. MirDivisha Raheja Original Article 10 January 2015 Pages: 1011 - 1016
Quality of life in multiple myeloma: clinical validation of the Mexican-Spanish version of the QLQ-MY20 instrument José Ramiro Espinoza-ZamoraCésar Miguel Portilla-EspinosaLuis F. Oñate-Ocaña Original Article 08 January 2015 Pages: 1017 - 1024
Increased expression of T cell immune response cDNA 7 in patients with acute graft-versus-host disease Feng ZhuJianlin QiaoKai-lin Xu Original Article 28 January 2015 Pages: 1025 - 1032
Allogeneic transplantation with myeloablative FluBu4 conditioning improves survival compared to reduced intensity FluBu2 conditioning for acute myeloid leukemia in remission John M. MagenauThomas BraunSteven C. Goldstein Original Article 19 March 2015 Pages: 1033 - 1041
Cytomegalovirus retinitis complicating combination therapy with rituximab and fludarabine Thomas S. Y. ChanCarol Y. M. CheungYok-Lam Kwong Original Article 10 January 2015 Pages: 1043 - 1047
FLT3 internal tandem duplication in acute promyelocytic leukemia: central nervous system relapse Harinder GillHo-Wan IpYok-Lam Kwong Letter to the Editor 19 December 2014 Pages: 1049 - 1051
Disappointing response to dapsone as second line therapy for primary ITP: a case series Thet OoQuentin A. Hill Letter to the Editor 21 December 2014 Pages: 1053 - 1054
Refractory mixed autoimmune hemolysis, thrombocytopenia, and thrombosis: a diagnostic puzzle S. KlassenM. WangM. Verhovsek Letter to the Editor 07 January 2015 Pages: 1055 - 1056
Late-onset hemophagocytic lymphohistiocytosis (HLH) in an adult female with Griscelli syndrome type 2 (GS2) Martin HenkesJürgen FinkeWolfram Brugger Letter to the Editor 30 December 2014 Pages: 1057 - 1060
Multiple asymptomatic colon plasmacytomas: a diagnostic and therapeutic dilemma Abhisek SwaikaPooja P. AdvaniSikander Ailawadhi Letter to the Editor 23 December 2014 Pages: 1061 - 1062
Validation of an enhanced International Prognostic Index (NCCN-IPI) in an Asian cohort of patients with diffuse large B cell lymphoma Cih-En HuangYi-Yang ChenChih-Cheng Chen Letter to the Editor 07 January 2015 Pages: 1063 - 1065
Synchronous presentation of monoclonal gammopathy and Fabry nephropathy; diagnostic renal biopsy obviates initiation of myeloma therapy Venkata K. PokuriBo XuPhilip L. McCarthy Letter to the Editor 10 February 2015 Pages: 1067 - 1068
Rituximab as frontline monotherapy in untreated hairy cell leukemia patients K. AkinosoglouM. MelachrinouE. E. Solomou Letter to the Editor 13 February 2015 Pages: 1069 - 1070
Acquired epidermodysplasia verruciformis, a new opportunistic infection related to bendamustine P. CougoulE. TournierV. Sibaud Letter to the Editor 14 February 2015 Pages: 1071 - 1073
Recurrence of persistent polyclonal B lymphocytosis (PPBL) after rituximab treatment C. WehrL. HouetKlaus Warnatz Letter to the Editor 01 February 2015 Pages: 1075 - 1076
Hepatosplenic γδ T-cell lymphoma after allogeneic bone marrow transplantation Marie-Christiane VekemansLucienne MichauxAugustin Ferrant Letter to the Editor 30 January 2015 Pages: 1077 - 1078
Erratum to: Atypical chronic myeloid leukemia with concomitant CSF3R T618I and SETBP1 mutations unresponsive to the JAK inhibitor ruxolitinib Emanuele AmmatunaMatthias EeftingIvo P. Touw Erratum 31 March 2015 Pages: 1079 - 1079